Esperion Therapeutics
ESPR
#6820
Rank
A$0.67 B
Marketcap
$3.46
Share price
8.06%
Change (1 day)
141.63%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$1.05 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are A$1.05 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.96 B15.44%
2022-12-31A$0.84 B5.28%
2021-12-31A$0.79 B36.54%
2020-12-31A$0.58 B110.38%
2019-12-31A$0.27 B204.2%
2018-12-31A$91.32 M115.1%
2017-12-31A$42.45 M84.23%
2016-12-31A$23.04 M101.94%
2015-12-31A$11.41 M-3.94%
2014-12-31A$11.87 M152.11%
2013-12-31A$4.71 M-80.18%
2012-12-31A$23.77 M195.91%
2011-12-31A$8.03 M
2002-12-31A$22.47 M-3.13%
2001-12-31A$23.2 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.79 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.17 B 106.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$192.42 B 18,121.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.30 B 1,065.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.92 B-12.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.20 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA